Best Practices for Virtual Care: A Consensus Statement From the Canadian Rheumatology Association

Claire E.H. Barber; Deborah M. Levy; Vandana Ahluwalia; Arielle Mendel; Regina Taylor-Gjevre; Tommy Gerschman; Sahil Koppikar; Konstantin Jilkine; Elizabeth Stringer; Cheryl Barnabe; Sibel Zehra Aydin; Nadia Luca; Roberta Berard; Keith Tam; Jennifer Burt; Jocelyne C. Murdoch; Graeme Zinck; Therese Lane; Jennifer Heeley; Megan Mannerow; Renee Mills; Linda Wilhelm; Nicole M.S. Hartfeld; Brent Ohata

doi:10.3899/jrheum.211017

Best Practices for Virtual Care: A Consensus Statement From the Canadian Rheumatology Association

Claire E.H. Barber, Deborah M. Levy, Vandana Ahluwalia, Arielle Mendel, Regina Taylor-Gjevre, Tommy Gerschman, Sahil Koppikar, Konstantin Jilkine, Elizabeth Stringer, Cheryl Barnabe, Sibel Zehra Aydin, Nadia Luca, Roberta Berard, Keith Tam, Jennifer Burt, Jocelyne C. Murdoch, Graeme Zinck, Therese Lane, Jennifer Heeley, Megan MannerowRenee Mills, Linda Wilhelm, Nicole M.S. Hartfeld, Brent Ohata

Medicine

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

Abstract

Objective. To develop best practice statements for the provision of virtual care in adult and pediatric rheumatology for the Canadian Rheumatology Association's (CRA) Telehealth Working Group (TWG). Methods. Four members of the TWG representing adult, pediatric, university-based, and community rheumatology practices defined the scope of the project. A rapid literature review of existing systematic reviews, policy documents, and published literature and abstracts on the topic was conducted between April and May 2021. The review informed a candidate set of 7 statements and a supporting document. The statements were submitted to a 3-round (R) modified Delphi process with 22 panelists recruited through the CRA and patient advocacy organizations. Panelists rated the importance and feasibility of the statements on a Likert scale of 1-9. Statements with final median ratings between 7-9 with no disagreement were retained in the final set. Results. Twenty-one (95%) panelists participated in R1, 15 (71%) in R2, and 18 (82%) in R3. All but 1 statement met inclusion criteria during R1. Revisions were made to 5/7 statements following R2 and an additional statement was added. All statements met inclusion criteria following R3. The statements addressed the following themes in the provision of virtual care: adherence to existing standards and regulations, appropriateness, consent, physical examination, patient-reported outcomes, use in addition to in-person visits, and complex comanagement of disease. Conclusion. The best practice statements represent a starting point for advancing virtual care in rheumatology. Future educational efforts to help implement these best practices and research to address identified knowledge gaps are planned.

Original language	English
Pages (from-to)	408-418
Number of pages	11
Journal	Journal of Rheumatology
Volume	49
Issue number	4
DOIs	https://doi.org/10.3899/jrheum.211017
Publication status	Published - Apr 1 2022

Bibliographical note

Funding Information:
CEHB has an Arthritis Society Career Development Award, funded by the Canadian Institutes of Health Research–Institute of Musculoskeletal Health and Arthritis STAR-19-0611/CIHR SI2-169745. CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. 1C.E.H. Barber, MD, PhD, FRCPC, Associate Professor, C. Barnabe, MD, MSc, FRCPC, Professor, Department of Medicine, and Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Arthritis Research Canada, Vancouver, British Columbia, and McCaig Institute for Bone and Joint Health, University of Calgary, Alberta; 2D.M. Levy, MD, MS, FRCPC, Associate Professor, Hospital for Sick Children, Toronto, and Department of Pediatrics, Division of Pediatric Rheumatology, University of Toronto, Toronto, Ontario; 3V. Ahluwalia, MD, FRCPC, William Osler Health System, Department of Medicine, Division of Rheumatology, Brampton, Ontario; 4A. Mendel, MD, FRCPC, MSc, Assistant Professor, Department of Medicine, Division of Rheumatology, McGill University Health Centre, and Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec; 5R. Taylor-Gjevre, MD, MSc, FRCPC, DRCPC, Professor of Medicine, Department of Medicine, Division of Rheumatology, University of Saskatchewan, Saskatoon, Saskatchewan; 6T. Gerschman, MD, MSc, Department of Pediatrics, Division of Pediatric Rheumatology, University of British Columbia, Vancouver, British Columbia; 7S. Koppikar, MD, FRCPC, Women’s College Hospital, Toronto, Timmins and District Hospital, Timmins, and Department of Medicine, Division of Rheumatology, University of Toronto, Toronto, Ontario; 8K. Jilkine, MD, FRCPC, Assistant Professor of Medicine, Department of Medicine, Division of Rheumatology, University of Manitoba, Winnipeg, Manitoba; 9E. Stringer, MD, MSc, FRCPC, Associate Professor of Pediatrics, Department of Pediatrics, Division of Pediatric Rheumatology, Dalhousie University, Halifax, Nova Scotia; 10S.Z. Aydin, MD, Associate Professor, Department of Medicine, Division of Rheumatology, University of Ottawa, Ottawa, The Ottawa Hospital Research Institute, Ottawa, Ontario; 11N. Luca, MD, MSc, FRCPC, Clinical Associate Professor, Department of Pediatrics, Section of Rheumatology, University of Calgary, and Alberta Children’s Hospital Research Institute, Calgary, Alberta; 12R. Berard, MD, MSc, FRCPC, Associate Professor of Pediatrics, Department of Pediatrics, Division of Rheumatology, Western University, London, Ontario; 13K. Tam, MD, N.M.S. Hartfeld, MSc, MC, CCC, Department of Medicine, University of Calgary, Calgary, Alberta; 14J. Burt, BScPT, ACPAC ERP, Division of Rheumatology, Eastern Health, Eastern Health, St. John’s, Newfoundland; 15J.C. Murdoch, BScOT, ACPAC ERP, Arthritis Society, Toronto, Ontario; 16G. Zinck, Patient Partner, J. Heeley, BSW, Parent Partner, M. Mannerow, Parent Partner, R. Mills, Patient Partner, Cassie + Friends, Vancouver, British Columbia; 17T. Lane, BScN, Patient Partner, L. Wilhelm, Patient Partner, Canadian Arthritis Patient

Funding Information:
CEHB has an Arthritis Society Career Development Award, funded by the Canadian Institutes of Health Research-Institute of Musculoskeletal Health and Arthritis STAR-19-0611/CIHR SI2-169745.

Publisher Copyright:
© 2022 The Journal of Rheumatology

ASJC Scopus Subject Areas

Immunology and Allergy
Rheumatology
Immunology

PubMed: MeSH publication types

Consensus Development Conference
Journal Article

Access to Document

10.3899/jrheum.211017

Cite this

Barber, C. E. H., Levy, D. M., Ahluwalia, V., Mendel, A., Taylor-Gjevre, R., Gerschman, T., Koppikar, S., Jilkine, K., Stringer, E., Barnabe, C., Aydin, S. Z., Luca, N., Berard, R., Tam, K., Burt, J., Murdoch, J. C., Zinck, G., Lane, T., Heeley, J., ... Ohata, B. (2022). Best Practices for Virtual Care: A Consensus Statement From the Canadian Rheumatology Association. Journal of Rheumatology, 49(4), 408-418. https://doi.org/10.3899/jrheum.211017

Barber, CEH, Levy, DM, Ahluwalia, V, Mendel, A, Taylor-Gjevre, R, Gerschman, T, Koppikar, S, Jilkine, K, Stringer, E, Barnabe, C, Aydin, SZ, Luca, N, Berard, R, Tam, K, Burt, J, Murdoch, JC, Zinck, G, Lane, T, Heeley, J, Mannerow, M, Mills, R, Wilhelm, L, Hartfeld, NMS & Ohata, B 2022, 'Best Practices for Virtual Care: A Consensus Statement From the Canadian Rheumatology Association', Journal of Rheumatology, vol. 49, no. 4, pp. 408-418. https://doi.org/10.3899/jrheum.211017

@article{9ab65f199ea64cac954268d13ab62f3c,

title = "Best Practices for Virtual Care: A Consensus Statement From the Canadian Rheumatology Association",

abstract = "Objective. To develop best practice statements for the provision of virtual care in adult and pediatric rheumatology for the Canadian Rheumatology Association's (CRA) Telehealth Working Group (TWG). Methods. Four members of the TWG representing adult, pediatric, university-based, and community rheumatology practices defined the scope of the project. A rapid literature review of existing systematic reviews, policy documents, and published literature and abstracts on the topic was conducted between April and May 2021. The review informed a candidate set of 7 statements and a supporting document. The statements were submitted to a 3-round (R) modified Delphi process with 22 panelists recruited through the CRA and patient advocacy organizations. Panelists rated the importance and feasibility of the statements on a Likert scale of 1-9. Statements with final median ratings between 7-9 with no disagreement were retained in the final set. Results. Twenty-one (95%) panelists participated in R1, 15 (71%) in R2, and 18 (82%) in R3. All but 1 statement met inclusion criteria during R1. Revisions were made to 5/7 statements following R2 and an additional statement was added. All statements met inclusion criteria following R3. The statements addressed the following themes in the provision of virtual care: adherence to existing standards and regulations, appropriateness, consent, physical examination, patient-reported outcomes, use in addition to in-person visits, and complex comanagement of disease. Conclusion. The best practice statements represent a starting point for advancing virtual care in rheumatology. Future educational efforts to help implement these best practices and research to address identified knowledge gaps are planned.",

author = "Barber, {Claire E.H.} and Levy, {Deborah M.} and Vandana Ahluwalia and Arielle Mendel and Regina Taylor-Gjevre and Tommy Gerschman and Sahil Koppikar and Konstantin Jilkine and Elizabeth Stringer and Cheryl Barnabe and Aydin, {Sibel Zehra} and Nadia Luca and Roberta Berard and Keith Tam and Jennifer Burt and Murdoch, {Jocelyne C.} and Graeme Zinck and Therese Lane and Jennifer Heeley and Megan Mannerow and Renee Mills and Linda Wilhelm and Hartfeld, {Nicole M.S.} and Brent Ohata",

note = "Funding Information: CEHB has an Arthritis Society Career Development Award, funded by the Canadian Institutes of Health Research–Institute of Musculoskeletal Health and Arthritis STAR-19-0611/CIHR SI2-169745. CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. 1C.E.H. Barber, MD, PhD, FRCPC, Associate Professor, C. Barnabe, MD, MSc, FRCPC, Professor, Department of Medicine, and Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Arthritis Research Canada, Vancouver, British Columbia, and McCaig Institute for Bone and Joint Health, University of Calgary, Alberta; 2D.M. Levy, MD, MS, FRCPC, Associate Professor, Hospital for Sick Children, Toronto, and Department of Pediatrics, Division of Pediatric Rheumatology, University of Toronto, Toronto, Ontario; 3V. Ahluwalia, MD, FRCPC, William Osler Health System, Department of Medicine, Division of Rheumatology, Brampton, Ontario; 4A. Mendel, MD, FRCPC, MSc, Assistant Professor, Department of Medicine, Division of Rheumatology, McGill University Health Centre, and Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec; 5R. Taylor-Gjevre, MD, MSc, FRCPC, DRCPC, Professor of Medicine, Department of Medicine, Division of Rheumatology, University of Saskatchewan, Saskatoon, Saskatchewan; 6T. Gerschman, MD, MSc, Department of Pediatrics, Division of Pediatric Rheumatology, University of British Columbia, Vancouver, British Columbia; 7S. Koppikar, MD, FRCPC, Women{\textquoteright}s College Hospital, Toronto, Timmins and District Hospital, Timmins, and Department of Medicine, Division of Rheumatology, University of Toronto, Toronto, Ontario; 8K. Jilkine, MD, FRCPC, Assistant Professor of Medicine, Department of Medicine, Division of Rheumatology, University of Manitoba, Winnipeg, Manitoba; 9E. Stringer, MD, MSc, FRCPC, Associate Professor of Pediatrics, Department of Pediatrics, Division of Pediatric Rheumatology, Dalhousie University, Halifax, Nova Scotia; 10S.Z. Aydin, MD, Associate Professor, Department of Medicine, Division of Rheumatology, University of Ottawa, Ottawa, The Ottawa Hospital Research Institute, Ottawa, Ontario; 11N. Luca, MD, MSc, FRCPC, Clinical Associate Professor, Department of Pediatrics, Section of Rheumatology, University of Calgary, and Alberta Children{\textquoteright}s Hospital Research Institute, Calgary, Alberta; 12R. Berard, MD, MSc, FRCPC, Associate Professor of Pediatrics, Department of Pediatrics, Division of Rheumatology, Western University, London, Ontario; 13K. Tam, MD, N.M.S. Hartfeld, MSc, MC, CCC, Department of Medicine, University of Calgary, Calgary, Alberta; 14J. Burt, BScPT, ACPAC ERP, Division of Rheumatology, Eastern Health, Eastern Health, St. John{\textquoteright}s, Newfoundland; 15J.C. Murdoch, BScOT, ACPAC ERP, Arthritis Society, Toronto, Ontario; 16G. Zinck, Patient Partner, J. Heeley, BSW, Parent Partner, M. Mannerow, Parent Partner, R. Mills, Patient Partner, Cassie + Friends, Vancouver, British Columbia; 17T. Lane, BScN, Patient Partner, L. Wilhelm, Patient Partner, Canadian Arthritis Patient Funding Information: CEHB has an Arthritis Society Career Development Award, funded by the Canadian Institutes of Health Research-Institute of Musculoskeletal Health and Arthritis STAR-19-0611/CIHR SI2-169745. Publisher Copyright: {\textcopyright} 2022 The Journal of Rheumatology",

year = "2022",

month = apr,

day = "1",

doi = "10.3899/jrheum.211017",

language = "English",

volume = "49",

pages = "408--418",

journal = "Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology",

number = "4",

}

TY - JOUR

T1 - Best Practices for Virtual Care

T2 - A Consensus Statement From the Canadian Rheumatology Association

AU - Barber, Claire E.H.

AU - Levy, Deborah M.

AU - Ahluwalia, Vandana

AU - Mendel, Arielle

AU - Taylor-Gjevre, Regina

AU - Gerschman, Tommy

AU - Koppikar, Sahil

AU - Jilkine, Konstantin

AU - Stringer, Elizabeth

AU - Barnabe, Cheryl

AU - Aydin, Sibel Zehra

AU - Luca, Nadia

AU - Berard, Roberta

AU - Tam, Keith

AU - Burt, Jennifer

AU - Murdoch, Jocelyne C.

AU - Zinck, Graeme

AU - Lane, Therese

AU - Heeley, Jennifer

AU - Mannerow, Megan

AU - Mills, Renee

AU - Wilhelm, Linda

AU - Hartfeld, Nicole M.S.

AU - Ohata, Brent

N1 - Funding Information: CEHB has an Arthritis Society Career Development Award, funded by the Canadian Institutes of Health Research–Institute of Musculoskeletal Health and Arthritis STAR-19-0611/CIHR SI2-169745. CB is a Canada Research Chair in Rheumatoid Arthritis and Autoimmune Diseases. 1C.E.H. Barber, MD, PhD, FRCPC, Associate Professor, C. Barnabe, MD, MSc, FRCPC, Professor, Department of Medicine, and Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Arthritis Research Canada, Vancouver, British Columbia, and McCaig Institute for Bone and Joint Health, University of Calgary, Alberta; 2D.M. Levy, MD, MS, FRCPC, Associate Professor, Hospital for Sick Children, Toronto, and Department of Pediatrics, Division of Pediatric Rheumatology, University of Toronto, Toronto, Ontario; 3V. Ahluwalia, MD, FRCPC, William Osler Health System, Department of Medicine, Division of Rheumatology, Brampton, Ontario; 4A. Mendel, MD, FRCPC, MSc, Assistant Professor, Department of Medicine, Division of Rheumatology, McGill University Health Centre, and Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec; 5R. Taylor-Gjevre, MD, MSc, FRCPC, DRCPC, Professor of Medicine, Department of Medicine, Division of Rheumatology, University of Saskatchewan, Saskatoon, Saskatchewan; 6T. Gerschman, MD, MSc, Department of Pediatrics, Division of Pediatric Rheumatology, University of British Columbia, Vancouver, British Columbia; 7S. Koppikar, MD, FRCPC, Women’s College Hospital, Toronto, Timmins and District Hospital, Timmins, and Department of Medicine, Division of Rheumatology, University of Toronto, Toronto, Ontario; 8K. Jilkine, MD, FRCPC, Assistant Professor of Medicine, Department of Medicine, Division of Rheumatology, University of Manitoba, Winnipeg, Manitoba; 9E. Stringer, MD, MSc, FRCPC, Associate Professor of Pediatrics, Department of Pediatrics, Division of Pediatric Rheumatology, Dalhousie University, Halifax, Nova Scotia; 10S.Z. Aydin, MD, Associate Professor, Department of Medicine, Division of Rheumatology, University of Ottawa, Ottawa, The Ottawa Hospital Research Institute, Ottawa, Ontario; 11N. Luca, MD, MSc, FRCPC, Clinical Associate Professor, Department of Pediatrics, Section of Rheumatology, University of Calgary, and Alberta Children’s Hospital Research Institute, Calgary, Alberta; 12R. Berard, MD, MSc, FRCPC, Associate Professor of Pediatrics, Department of Pediatrics, Division of Rheumatology, Western University, London, Ontario; 13K. Tam, MD, N.M.S. Hartfeld, MSc, MC, CCC, Department of Medicine, University of Calgary, Calgary, Alberta; 14J. Burt, BScPT, ACPAC ERP, Division of Rheumatology, Eastern Health, Eastern Health, St. John’s, Newfoundland; 15J.C. Murdoch, BScOT, ACPAC ERP, Arthritis Society, Toronto, Ontario; 16G. Zinck, Patient Partner, J. Heeley, BSW, Parent Partner, M. Mannerow, Parent Partner, R. Mills, Patient Partner, Cassie + Friends, Vancouver, British Columbia; 17T. Lane, BScN, Patient Partner, L. Wilhelm, Patient Partner, Canadian Arthritis Patient Funding Information: CEHB has an Arthritis Society Career Development Award, funded by the Canadian Institutes of Health Research-Institute of Musculoskeletal Health and Arthritis STAR-19-0611/CIHR SI2-169745. Publisher Copyright: © 2022 The Journal of Rheumatology

PY - 2022/4/1

Y1 - 2022/4/1

N2 - Objective. To develop best practice statements for the provision of virtual care in adult and pediatric rheumatology for the Canadian Rheumatology Association's (CRA) Telehealth Working Group (TWG). Methods. Four members of the TWG representing adult, pediatric, university-based, and community rheumatology practices defined the scope of the project. A rapid literature review of existing systematic reviews, policy documents, and published literature and abstracts on the topic was conducted between April and May 2021. The review informed a candidate set of 7 statements and a supporting document. The statements were submitted to a 3-round (R) modified Delphi process with 22 panelists recruited through the CRA and patient advocacy organizations. Panelists rated the importance and feasibility of the statements on a Likert scale of 1-9. Statements with final median ratings between 7-9 with no disagreement were retained in the final set. Results. Twenty-one (95%) panelists participated in R1, 15 (71%) in R2, and 18 (82%) in R3. All but 1 statement met inclusion criteria during R1. Revisions were made to 5/7 statements following R2 and an additional statement was added. All statements met inclusion criteria following R3. The statements addressed the following themes in the provision of virtual care: adherence to existing standards and regulations, appropriateness, consent, physical examination, patient-reported outcomes, use in addition to in-person visits, and complex comanagement of disease. Conclusion. The best practice statements represent a starting point for advancing virtual care in rheumatology. Future educational efforts to help implement these best practices and research to address identified knowledge gaps are planned.

AB - Objective. To develop best practice statements for the provision of virtual care in adult and pediatric rheumatology for the Canadian Rheumatology Association's (CRA) Telehealth Working Group (TWG). Methods. Four members of the TWG representing adult, pediatric, university-based, and community rheumatology practices defined the scope of the project. A rapid literature review of existing systematic reviews, policy documents, and published literature and abstracts on the topic was conducted between April and May 2021. The review informed a candidate set of 7 statements and a supporting document. The statements were submitted to a 3-round (R) modified Delphi process with 22 panelists recruited through the CRA and patient advocacy organizations. Panelists rated the importance and feasibility of the statements on a Likert scale of 1-9. Statements with final median ratings between 7-9 with no disagreement were retained in the final set. Results. Twenty-one (95%) panelists participated in R1, 15 (71%) in R2, and 18 (82%) in R3. All but 1 statement met inclusion criteria during R1. Revisions were made to 5/7 statements following R2 and an additional statement was added. All statements met inclusion criteria following R3. The statements addressed the following themes in the provision of virtual care: adherence to existing standards and regulations, appropriateness, consent, physical examination, patient-reported outcomes, use in addition to in-person visits, and complex comanagement of disease. Conclusion. The best practice statements represent a starting point for advancing virtual care in rheumatology. Future educational efforts to help implement these best practices and research to address identified knowledge gaps are planned.

UR - http://www.scopus.com/inward/record.url?scp=85127522540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85127522540&partnerID=8YFLogxK

U2 - 10.3899/jrheum.211017

DO - 10.3899/jrheum.211017

M3 - Article

C2 - 35105707

AN - SCOPUS:85127522540

SN - 0315-162X

VL - 49

SP - 408

EP - 418

JO - Journal of Rheumatology

JF - Journal of Rheumatology

IS - 4

ER -

Best Practices for Virtual Care: A Consensus Statement From the Canadian Rheumatology Association

Abstract

Bibliographical note

ASJC Scopus Subject Areas

PubMed: MeSH publication types

Access to Document

Other files and links

Fingerprint

Cite this